This is a safety measure to prevent the transmission of the virus through plasma-based medicinal therapies
In contrast to the majority of anti-diabetic compounds, DPP-4 inhibitors do not produce weight gain as a side effect, which is crucial for limiting body weight gain during long-term therapy for diabetes
Thats the highest amount of weight loss recorded for any pharmaceutical obesity treatment
Be pregnant or take medications that interact with Semaglutide
Patients with certain genetic variants may benefit from staying at a lower but consistent dose, while others respond better to the standard therapeutic range
JACC Heart Fail 4(7):559566 Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hnselmann A, Nilsson B, Mller JE, Hjort J, Rasmussen J, Boesgaard TW, Schou M, Videbaek L, Gustafsson I, Flyvbjerg A, Wiggers H, Tarnow L (2017) Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial
